A Case of Encephalopathy in an Immunocompetent Adult with Persistent Parvovirus B19 Viremia



Ariel Antezana1, *, Ilya Kister2, Joseph Herbert2
1 Neuromedical Clinic of Central Louisiana, Alexandria, LA, USA
2 NYU School of Medicine, New York, NY, USA


Article Metrics

CrossRef Citations:
0
Total Statistics:

Full-Text HTML Views: 371
Abstract HTML Views: 277
PDF Downloads: 113
Total Views/Downloads: 761
Unique Statistics:

Full-Text HTML Views: 236
Abstract HTML Views: 154
PDF Downloads: 84
Total Views/Downloads: 474



© Antezana et al.; Licensee Bentham Open.

open-access license: This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.

* Address correspondence to this author at the Neuromedical Clinic of Central Louisiana, Alexandria, LA, USA;, E-mail: antezana.neuromed@gmail.com


Abstract

Parvovirus B19 (PVB19) is a ubiquitous airborne virus; it is well known to cause erythema infectiosum (fifth disease) in children. Neurologic complications after PVB19 exposure are thought to be transitory and infrequent in the adult population. Herein, we report an interesting case of a young woman who developed cognitive deficits, white matter changes and persisting viremia for over a year after exposure to PVB19.

Keywords: Cognitive deficits, encephalopathy, parvovirus B19, white matter changes.